Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Filing metadata referenced "Encompass Health Corp," but the document text identifies the registrant as HealthSouth Corporation).
Reporting Period: Quarterly period ended March 31, 2009 (Form 10-Q).
Business Overview: The nation's largest provider of inpatient rehabilitative healthcare services, operating 93 inpatient rehabilitation hospitals, 6 long-term acute care hospitals, and various outpatient and home health agencies across 26 states and Puerto Rico.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 (As Adjusted) |
|---|---|---|
| Net Operating Revenues | $475.1 million | $464.2 million |
| Net Income | $53.5 million | $26.4 million |
| Net Income Attributable to HealthSouth | $44.9 million | $19.8 million |
| Diluted EPS (Common Shareholders) | $0.44 | $0.17 |
| Operating Cash Flow | $183.1 million | $41.8 million |
| Total Debt Outstanding | $1,728.1 million | $1,813.2 million |
| Cash and Cash Equivalents | $90.7 million | $32.2 million |
| Adjusted Consolidated EBITDA | $98.7 million | $89.2 million |
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 2.3% year-over-year, driven by a 5.7% increase in inpatient discharges, partially offset by a Medicare pricing "roll-back" that reduced revenue per discharge.
- Profitability Surge: Net income attributable to HealthSouth more than doubled (126.8% increase). This was significantly aided by a $15.9 million gain from the reduction of securities litigation liabilities (compared to a $36.4 million gain in Q1 2008) and a substantial decrease in interest expense due to debt reduction.
- Debt Reduction: Total debt decreased by approximately $85 million during the quarter. The company used federal tax refunds and proceeds from the UBS settlement to pay down the Term Loan Facility and redeem $15.4 million of Floating Rate Senior Notes.
- Cash Flow Improvement: Operating cash flow increased to $183.1 million, bolstered by $73.8 million in net proceeds from the UBS settlement and a $42 million federal income tax refund.
- Discontinued Operations: Q1 2008 included a $19.3 million gain on the divestiture of surgery centers, whereas Q1 2009 reported a loss of $2.8 million from discontinued operations.
Guidance, Outlook, and Risks
- Deleveraging Strategy: Management's primary focus remains debt reduction. The company aims to achieve a leverage ratio of 4.5x or below by year-end 2010 and a long-term target of 3.5x to 4.0x by the end of 2012.
- Regulatory Environment: The company faces a Medicare pricing "roll-back" effective through September 30, 2009. Management is monitoring a proposed "bundling" of acute and post-acute care payments, which could impact reimbursement models.
- Liquidity: The company maintains $90.7 million in unrestricted cash and has a $400 million revolving credit facility with no current draws. It is in compliance with all financial covenants.
- Legal Contingencies: Significant ongoing litigation includes the Tucker derivative litigation (trial against former CEO Richard Scrushy set for May 2009), arbitration with former auditor Ernst & Young, and a pending appeal regarding the AIG opt-out from the securities class action settlement.
- Capital Expenditures: Expected to range between $70 million and $85 million for 2009, with approximately $35 million designated as non-discretionary.
Investor Verification Checklist
- Debt Covenant Compliance: Verify continued compliance with the leverage and interest coverage ratios in the Credit Agreement, especially given the high debt load relative to equity.
- Medicare Reimbursement: Monitor the expiration of the Medicare pricing roll-back in Q3 2009 and the potential impact of proposed "bundling" regulations on future revenue per discharge.
- Legal Settlements: Track the outcome of the Tucker derivative litigation trial (May 2009) and the AIG appeal, as these could result in significant, non-recurring charges or liabilities.
- Discontinued Operations: Confirm the timeline for the final transfer of the remaining Illinois surgery center facility, which could trigger a deferred gain of $10 million to $16 million.
- Interest Rate Exposure: Assess the impact of the $1.1 billion interest rate swap on cash flows, noting that a 1% decrease in rates could result in negative cash flow due to the hedging position.